Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vicky Goh

Showing results (201-210 of 214) with videos related to

Pageof 22
Sort By:
European Radiology|June 5, 2024
Multivariable prognostic modelling to improve prediction of colorectal cancer recurrence: the PROSPeCT trialVicky Goh, Susan Mallett, Victor Boulter, et al.
The Lancet. Oncology|February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trialJanet E Brown, Kara-Louise Royle, Walter Gregory, et al.
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCTFiona Collinson, Kara-Louise Royle, Jayne Swain, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
Investigative Radiology|June 26, 2023
Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer: A Diagnostic Test Accuracy StudyAndrea G Rockall, Xingfeng Li, Nicholas Johnson, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
Gut|September 14, 2025
Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exerciseChristopher M Jones, Wee Han Ng, Laura Tincknell, et al.
BMC Medicine|January 24, 2025
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meetingMartina A McAteer, Daniel R McGowan, Gary J R Cook, et al.
Journal of Medical Imaging and Radiation Sciences|July 27, 2024
A multidisciplinary team and multiagency approach for AI implementation: A commentary for medical imaging and radiotherapy key stakeholdersNikolaos Stogiannos, Caitlin Gillan, Helle Precht, et al.
Pageof 22

Showing results (201-210 of 214) with videos related to

Sort By:
Pageof 22
European Radiology|June 5, 2024
Multivariable prognostic modelling to improve prediction of colorectal cancer recurrence: the PROSPeCT trialVicky Goh, Susan Mallett, Victor Boulter, et al.
The Lancet. Oncology|February 16, 2023
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trialJanet E Brown, Kara-Louise Royle, Walter Gregory, et al.
The Lancet. Oncology|May 7, 2025
Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trialAlexandra Gilbert, Richard Adams, Joanne Webster, et al.
Health Technology Assessment (Winchester, England)|September 9, 2024
Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCTFiona Collinson, Kara-Louise Royle, Jayne Swain, et al.
The Lancet. Respiratory Medicine|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trialStuart A Taylor, Sue Mallett, Simon Ball, et al.
Investigative Radiology|June 26, 2023
Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer: A Diagnostic Test Accuracy StudyAndrea G Rockall, Xingfeng Li, Nicholas Johnson, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
Gut|September 14, 2025
Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exerciseChristopher M Jones, Wee Han Ng, Laura Tincknell, et al.
BMC Medicine|January 24, 2025
Translation of PET radiotracers for cancer imaging: recommendations from the National Cancer Imaging Translational Accelerator (NCITA) consensus meetingMartina A McAteer, Daniel R McGowan, Gary J R Cook, et al.
Journal of Medical Imaging and Radiation Sciences|July 27, 2024
A multidisciplinary team and multiagency approach for AI implementation: A commentary for medical imaging and radiotherapy key stakeholdersNikolaos Stogiannos, Caitlin Gillan, Helle Precht, et al.
Pageof 22